Les aliments traditionnels : remèdes de bonne femme ou pharmacopée du xxie siècle l’exemple de la curcumine

Kelloff, 2000, Progress in cancer chemoprevention: development of diet-derived chemopreventive agents, J. Nutr., 130, 467, 10.1093/jn/130.2.467S Sharma, 2005, Curcumin: The story so far, Eur. J. Cancer., 41, 1955, 10.1016/j.ejca.2005.05.009 Arora, 1971, Anti-inflammatory studies on Curcuma longa [turmeric], Indian J. Med. Res., 59, 1289 Ammon, 1991, Pharmacology of Curcuma longa, Planta Med., 57, 1, 10.1055/s-2006-960004 Joe, 2004, Biological properties of curcumin-cellular and molecular mechanisms of action, Crit. Rev. Food. Sci. Nutr., 44, 97, 10.1080/10408690490424702 Shoba, 1998, Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers, Planta. Med., 64, 353, 10.1055/s-2006-957450 Sharma, 2004, Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance, Clin. Cancer. Res., 10, 6847, 10.1158/1078-0432.CCR-04-0744 Cynober, 2005, 10 Aggarwal, 2003, Anticancer potential of curcumin: preclinical and clinical studies, Anticancer. Res., 23, 363 Jobin, 1999, Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity, J. Immunol., 163, 3474, 10.4049/jimmunol.163.6.3474 Lee, 2005, Curcumin inhibits interferon-alpha induced NF-kappaB and COX-2 in human A549 non-small cell lung cancer cells, Biochem. Biophys. Res. Commun., 334, 313, 10.1016/j.bbrc.2005.06.093 Li, 2005, Liposome-encapsulated curcumin, Cancer, 104, 1322, 10.1002/cncr.21300 Plummer, 1999, Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex, Oncogene, 18, 6013, 10.1038/sj.onc.1202980 Shishodia, 2003, Curcumin [diferuloylmethane] down-regulates cigarette smoke-induced NF-kappaB activation through inhibition of IkappaBα kinase in human lung epithelial cells: correlation with suppression of COX-2 MMP-9 and cyclin D1, Carcinogenesis, 24, 1269, 10.1093/carcin/bgg078 Siwak, 2005, Cancer, 104, 879, 10.1002/cncr.21216 Woo, 2005, Curcumin suppresses phorbol ester-induced matrix metalloproteinase-9 expression by inhibiting the PKC to MAPK signaling pathways in human astroglioma cells, Biochem. Biophys. Res. Commun., 335, 1017, 10.1016/j.bbrc.2005.07.174 Cho, 2005, – Curcumin inhibits the expression of COX-2 in UVB-irradiated human keratinocytes [HaCaT] by inhibiting activation of AP-1: p38 MAP kinase and JNK as potential upstream targets, Exp. Mol. Med., 37, 186, 10.1038/emm.2005.25 Chen, 1998, Inhibition of the c-Jun N-terminal kinase [JNK] signaling pathway by curcumin, Oncogene, 17, 173, 10.1038/sj.onc.1201941 Anto, 1996, Antimutagenic and anticarcinogenic activity of natural and synthetic curcuminoids, Mutat. Res., 370, 127, 10.1016/0165-1218(96)00074-2 Duvoix, 2005, Chemopreventive and therapeutic effects of curcumin, Cancer. Lett., 223, 181, 10.1016/j.canlet.2004.09.041 Fullbeck, 2005, Novel curcumin- and emodin-related compounds identified by in silico 2D/3D conformer screening induce apoptosis in tumor cells, Bio Med. Central. Cancer., 5, 97 Conney, 2003, Enzyme induction and dietary chemicals as approaches to cancer chemoprevention: the Seventh DeWitt S, Goodman Lecture. Cancer. Res., 63, 7005 Barik, 2005, Evaluation of a new copper[II]-curcumin complex as superoxide dismutase mimic and its free radical reactions, Free Radic. Biol. Med., 39, 811, 10.1016/j.freeradbiomed.2005.05.005 Chan, 1998, In vivo inhibition of nitric oxide synthase gene expression by curcumin, a cancer preventive natural product with anti-inflammatory properties, Biochem. Pharmacol., 55, 1955, 10.1016/S0006-2952(98)00114-2 Dinkova-Kostova, 1999, Relation of structure of curcumin analogs to their potencies as inducers of Phase 2 detoxification enzymes, Carcinogenesis, 20, 911, 10.1093/carcin/20.5.911 Arbiser, 1998, Curcumin is an in vivo inhibitor of angiogenesis, Mol. Med., 4, 376, 10.1007/BF03401744 Gupta, 1999, Curcuma longa inhibits TNF-alpha induced expression of adhesion molecules on human umbilical vein endothelial cells, Int. J. Immunopharmacol., 21, 745, 10.1016/S0192-0561(99)00050-8 Jaiswal, 2002, Beta-catenin-mediated transactivation and cell-cell adhesion pathways are important in curcumin [diferuylmethane]-induced growth arrest and apoptosis in colon cancer cells, Oncogene, 21, 8414, 10.1038/sj.onc.1205947 Chan, 1995, Inhibition of tumor necrosis factor by curcumin, a phytochemical, Biochem. Pharmacol., 49, 1551, 10.1016/0006-2952(95)00171-U Chearwae, 2005, Curcuminoids purified from turmeric powder modulate the function of human multidrug resistance protein 1 [ABCC1], Cancer. Chemother. Pharmacol., 1 Tang, 2005, Effect of curcumin on multidrug resistance in resistant human gastric carcinoma cell line SGC7901/VCR, Acta Pharmacol. Sin., 6, 009 Kuttan, 1987, Turmeric and curcumin as topical agents in cancer therapy, Tumori, 73, 29, 10.1177/030089168707300105 Cheng, 2001, Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions, Anticancer. Res., 21, 2895 Sreepriya, 2005, Chemopreventive effects of embelin and curcumin against N-nitrosodiethylamine/phenobarbital-induced hepatocarcinogenesis in Wistar rats, Fitoterapia, 76, 549, 10.1016/j.fitote.2005.04.014 Arafa, 2005, Curcumin attenuates diet-induced hypercholesterolemia in rats, Med. Sci. Monit., 11, 228 Babu, 1997, Hypolipidemic action of curcumin, the active principle of turmeric [Curcuma longa] in streptozotocin induced diabetic rats, Mol. Cell. Biochem., 166, 169, 10.1023/A:1006819605211 Soudamini, 1992, Inhibition of lipid peroxidation and cholesterol levels in mice by curcumin, Indian. J. Physiol. Pharmacol., 36, 239 Soni, 1992, Effect of oral curcumin administration on serum peroxides and cholesterol levels in human volunteers, Indian. J. Physiol. Pharmacol., 36, 273 Ramaswami, 2004, Curcumin blocks homocysteine-induced endothelial dysfunction in porcine coronary arteries, J. Vasc. Surg., 40, 1216, 10.1016/j.jvs.2004.09.021 Arun, 2002, Efficacy of turmeric on blood sugar and polyol pathway in diabetic albino rats, Plant. Foods. Hum. Nutr., 57, 41, 10.1023/A:1013106527829 Nishiyama, 2005, Curcuminoids and sesquiterpenoids in turmeric [Curcuma longa L.] suppress an increase in blood glucose level in type 2 diabetic KK-Ay mice, J. Agric. Food. Chem., 53, 959, 10.1021/jf0483873 Suresh, 1998, Amelioration of renal lesions associated with diabetes by dietary curcumin in streptozotocin diabetic rats, Mol. Cell. Biochem., 181, 87, 10.1023/A:1006821828706 Kumar, 2005, Modulation of alpha-crystallin chaperone activity in diabetic rat lens by curcumin, Mol. Vis., 11, 561 Kang, 1999, Curcumin inhibits Th1 cytokine profile in CD4+ T cells by suppressing interleukin-12 production in macrophages, Br. J. Pharmacol., 128, 380, 10.1038/sj.bjp.0702803 Gao, 2004, Immunomodulatory activity of curcumin: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production in vitro, Biochem. Pharmacol., 68, 51, 10.1016/j.bcp.2004.03.015 Li, 2005, Effect of curcumin on immune function of mice, J. Huazhong. Univ. Sci. Technolog. Med. Sci., 25, 137, 10.1007/BF02873559 Suzuki, 2005, Elucidation of anti-allergic activities of curcumin-related compounds with a special reference to their anti-oxidative activities, Biol. Pharm. Bull., 28, 1438, 10.1248/bpb.28.1438 James, 1996, Curcumin: clinical trial finds no antiviral effect, AIDS Treat News, 242, 1 Mazumder, 1995, Inhibition of human immunodeficiency virus type-1 integrase by curcumin, Biochem. Pharmacol., 49, 1165, 10.1016/0006-2952(95)98514-A Hata, 1997, Allergic contact dermatitis from curcumin [turmeric], Contact. Dermatitis., 36, 107, 10.1111/j.1600-0536.1997.tb00426.x Rapport de l’AFSSA. Démarche d’évaluation de la sécurité, de l’intérêt et de l’allégation des denrées alimentaires contenant des plantes destinées à la consommation humaine. 27 février 2003 ; 1-38.